|
Website:
http://www.boehringer-ingelheim.com
Phone: +49 61 32 77 0 |
Address:
Binger Strasse 173
55216 Ingelheim, |
Company Description
Boehringer Ingelheim. The Group's principal activity is to manufacture, research and market of pharmaceutical products. The Group operates in two segments: Human Pharmaceuticals and Animal Health. Human Pharmaceuticals segment is sub divided into Prescription medicines, Consumer Health Care and Industrial Customer activities, which comprises chemicals, biopharmaceuticals and pharmaceutical manufacture. Animal Health segment introduces new products and product concepts for the treatment and prevention of diseases for animals. The Group also offers treatments for cancer and AIDS.
Key People
| Chairman | Dr. Alessandro Banchi |
| Chairman | Prof. Michael Hoffmann-Becking |
Related Business Topics
Breaking News
Reuters UK - November 27, 2009 3:14 AM
* Ends device deal with Boehringer Ingelheim * May now make generic version of Boehringer drug * Also clears the way for Novartis takeover * H1 revenue up 71 pct to 22.8 million pounds, beating view * Shares up 2.5 percent (Recasts, adds comments from ...
Reuters - November 27, 2009 2:12 AM
Closely following FDA approval, MICARDIS® is now indicated by the European Commission for the reduction of CV morbidity in patients with manifest atherothrombotic CV disease or type 2 diabetes with documented target organ damage. * MICARDIS® ...
The Economist - November 26, 2009 10:23 AM
BACK in the 1990s a drug firm called Pfizer thought it had a treatment for angina. Unfortunately, the new medicine failed its clinical trials. But a curious side-effect was seen in those trialsand Viagra was born. It has helped make Pfizer into a ...
[Subscription Required]
[Subscription Required]
BBC - November 26, 2009 4:45 AM
], 'clockwatch': W Winner of the Eco Hero award Russell Bryant with his award from Debbie McGee and Andrew Peach. The awards were hosted by Bracknell and Bracknell Regeneration Partnership at The Grange Hotel. The Education Champion award was presented ...
Reuters - November 25, 2009 11:55 AM
SOUTH SAN FRANCISCO, Calif.--(Business Wire)-- Exelixis, Inc. (NASDAQ:EXEL) announced today that Charles Butler, the company's vice president, investor relations and corporate communications, will present at Piper Jaffray's 21st Annual Healthcare ...
Free Prescription Program
Get Completely Free Medication from Over 270 Assistance Programs Today
www.FreeMedicineRevolution.com
Get Completely Free Medication from Over 270 Assistance Programs Today
www.FreeMedicineRevolution.com
Free Prescription Drugs
Free Medicine from 270+ Programs For Low Income Americans Under 65
www.scbn.org
Free Medicine from 270+ Programs For Low Income Americans Under 65
www.scbn.org
